本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 证券代码：688079 证券简称：美迪凯 公告编号：2025-026 杭州美迪凯光电科技股份有限公司 一、交易概述 杭州美迪凯光电科技股份有限公司（以下简称"公司"）于 2025 年 7 月 15 日 召开第三届董事会第二次会议，审议通过了《关于收购海硕力光电技术（苏州）有 限公司和 INNOWAVE VIETNAM CO.,LTD 两家公司 100%股权的议案》，一致同意以自有 资金或自筹资金 2,194,700 美元收购 KEM TECH CORP.持有的海硕力光电技术（苏州） 有限公司（以下简称"海硕力"）100%股权和 INNOWAVE CO.,LTD.持有的 INNOWAVE VIETNAM CO.,LTD.（以下简称"INNOWAVE VIETNAM"）100%股权。具体内容详见公 司于 2025 年 7 月 17 日在上海证券交易所网站（http://www.sse.com.cn/）及指定 媒体披露的《关于收购海硕力光电技术（苏州）有限公司和 INNOWAVE ...

证券代码：688079 证券简称：美迪凯 公告编号：2025-026 杭州美迪凯光电科技股份有限公司 关于收购资产完成的公告 2025 年 8 月 19 日 2 杭州美迪凯光电科技股份有限公司（以下简称"公司"）于 2025 年 7 月 15 日 召开第三届董事会第二次会议，审议通过了《关于收购海硕力光电技术（苏州）有 限公司和 INNOWAVE VIETNAM CO.,LTD 两家公司 100%股权的议案》，一致同意以自有 资金或自筹资金 2,194,700 美元收购 KEM TECH CORP.持有的海硕力光电技术（苏州） 有限公司（以下简称"海硕力"）100%股权和 INNOWAVE CO.,LTD.持有的 INNOWAVE VIETNAM CO.,LTD.（以下简称"INNOWAVE VIETNAM"）100%股权。具体内容详见公 司于 2025 年 7 月 17 日在上海证券交易所网站（http://www.sse.com.cn/）及指定 媒体披露的《关于收购海硕力光电技术（苏州）有限公司和 INNOWAVE VIETNAM CO.,LTD 两家公司 100%股权的公告》（公告编号：2025-024 ...

本文源自：金融界AI电报 美迪凯公告，公司以自有资金或自筹资金219.47万美元收购KEM TECHCORP.持有的海硕力光电技术 （苏州）有限公司100%股权和INNOWAVE CO.,LTD.持有的INNOWAVE VIETNAM CO.,LTD.100%股 权。截至2025年8月15日，本次交易涉及的两家标的公司股权交割已完成。海硕力和INNOWAVE VIETNAM成为公司的全资子公司，纳入合并报表范围。 ...

Group 1: Market Dynamics - The People's Bank of China (PBOC) supports more private technology enterprises and private equity investment institutions to issue bonds for financing, aiming to enhance the bond market and facilitate financing for quality private enterprises [2] - The PBOC emphasizes the development of a multi-tiered bond market and the promotion of the Panda bond market, while also advancing the internationalization of the Renminbi [2] Group 2: Company Developments - OpenAI plans to invest trillions of dollars in infrastructure for developing and operating AI services, indicating a significant commitment to data center construction [3] - Huahong Semiconductor is planning to acquire the controlling stake in Shanghai Huali Microelectronics to resolve competition issues, with its stock suspended for up to 10 trading days [9] - Shengyi Technology reported a 91% increase in revenue to 3.769 billion yuan and a 452% increase in net profit to 531 million yuan for the first half of 2025 [9] - Chipone Technology achieved a 40.32% revenue growth to 636 million yuan and a 106.02% increase in net profit to 90.49 million yuan in the same period [9] - Tianyue Advanced confirmed its H-share issuance price at 42.80 HKD per share, with trading expected to start on August 20, 2025 [11] Group 3: Technological Innovations - The first humanoid robot, "Embodied Tiangong Ultra," won the 100-meter sprint at the World Humanoid Robot Games with a time of 21.50 seconds, showcasing advancements in autonomous navigation [4] - The Chinese space station successfully utilized the "Wukong AI" model during an extravehicular activity, providing intelligent support to astronauts [5] - Shanghai Lingang launched its first batch of autonomous smart connected taxis, covering 58 locations with a fare structure starting at 16 yuan for trips under 5 kilometers [6] - ZhiYuan Robotics launched the OmniHand 2025 series, aimed at enhancing industrial manufacturing and service interactions, with a promotional price drop [7] Group 4: Industry Trends - Several photovoltaic companies have been invited to participate in a discussion organized by relevant authorities, indicating ongoing developments in the solar energy sector [8] - Tsinghua University achieved a significant breakthrough in quantum computing, developing a programming architecture for arbitrary two-qubit gates [15][16] - A collaborative effort led by Karolinska Institute has resulted in a method for designing new antibiotics using generative AI, addressing antibiotic resistance [16]

Group 1 - The meeting between US President Trump and Ukrainian President Zelensky is scheduled for August 18, with potential follow-up discussions involving US, Russia, and Ukraine leaders [2] - A-share indices reached new highs, with market analysts suggesting a focus on sectors like AI, innovative pharmaceuticals, non-ferrous metals, military industry, and large finance [2] - The upcoming National Day and Mid-Autumn Festival will have an 8-day holiday, with toll-free travel for small passenger vehicles on all toll roads [3] Group 2 - A-share market has seen a significant increase in stocks doubling in value, with over 310 stocks rising more than 100% this year, particularly in the pharmaceutical and machinery sectors [4] - CITIC Securities reports that market sentiment remains strong, with a focus on sectors such as innovative pharmaceuticals, resources, communications, military, and gaming [4] - As of August 15, 52.44% of funds established in 2021 have a net asset value above 1, indicating a recovery in the A-share market [5] Group 3 - Publicly offered funds of funds (FOFs) have shown strong performance this year, with 29 FOFs achieving over 20% returns, driven by heavy investments in high-volatility equity funds [6] - Notable private equity fund managers have increased their holdings in A-share companies, with significant investments in firms like Angel Yeast and Dao Technology [6] Group 4 - 25 companies listed on the Beijing Stock Exchange reported their 2025 semi-annual results, with 22 companies showing revenue growth, led by Zhuozhao Point Glue with a 207.46% increase [7] - China Shenhua, a state-owned enterprise, announced a major asset restructuring involving the acquisition of 10 companies and significant coal and energy assets [7] Group 5 - Hong Kong's financial secretary highlighted the ongoing development of a commodity trading ecosystem, aiming to position Hong Kong as an international gold trading center [19] - The first issuance of yen-denominated stablecoin JPYC is expected to be approved by Japan's Financial Services Agency, supporting its value with government bonds [13]

证券代码：688079 证券简称：美迪凯 公告编号：2025-025 杭州美迪凯光电科技股份有限公司 持股 5%以上股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： ? 大股东及董监高持有股份的基本情况 杭州美迪凯光电科技股份有限公司（以下简称"公司"）股东香港豐盛佳美 （國際）投資有限公司（以下简称"丰盛佳美"、"减持主体"）持有公司股份 份，且已于 2022 年 3 月 2 日解除限售并上市流通。 （一）相关股东是否有其他安排 □是 √否 （二）大股东及董监高此前对持股比例、持股数量、持股期限、减持方式、减 持数量、减持价格等是否作出承诺 √是 □否 公司其他持股 5%以上股东丰盛佳美承诺： "1.本企业自公司股票上市交易之日起十二个月内，不转让或者委托他人管 理本企业持有的公司股份，也不由公司回购该部分股份。 不同意见，同意按照监管部门的意见对上述锁定期安排进行修订并予以执行。 "1.本企业对于本次发行前所持有的公司股份，将严格遵守已做出的关于股 ? 减持计划的主要内容 ...

Summary of Key Points Core Viewpoint - On August 17, no A-share listed companies disclosed any increase in shareholding, while two companies, including Meidike and Nanwei Medical, announced share reductions [1]. Company Specifics - Meidike's shareholders plan to reduce their holdings by no more than 3% of the company's shares [2]. - Nanwei Medical's shareholder, Zhongke Investment, intends to reduce its stake by no more than 2% of the company's shares [2].

证券代码：688079 证券简称：美迪凯 公告编号：2025-025 杭州美迪凯光电科技股份有限公司 持股 5%以上股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 大股东及董监高持有股份的基本情况 杭州美迪凯光电科技股份有限公司（以下简称"公司"）股东香港豐盛佳美 （國際）投資有限公司（以下简称"丰盛佳美"、"减持主体"）持有公司股份 32,890,291 股，占公司总股本的 8.0864%。上述股份来源为公司 IPO 前取得股 份，且已于 2022 年 3 月 2 日解除限售并上市流通。 减持计划的主要内容 减持主体计划自本公告披露之日起 15 个交易日后即 2025 年 9 月 9 日起的 3 个月内，减持股份不超过 12,202,129 股，即不超过总股本的 3%，其中：通过集 中竞价方式减持公司股份不超过 4,067,376 股，即不超过公司总股本的 1%，通 过大宗交易方式减持公司股份不超过 8,134,753 股，即不超过公司总股本的 2%， 减持价格按市场价格 ...

Group 1 - The core point of the article is that Medike (688079) announced on August 17 that its shareholder, Hong Kong Fengsheng Jiamei (International) Investment Co., Ltd., plans to reduce its holdings by up to 12.2021 million shares, which is not more than 3% of the total share capital [1] Group 2 - The shareholder currently holds an 8.09% stake in Medike [1] - The planned share reduction is significant as it may impact the stock's market performance and investor sentiment [1] - The announcement was made in the evening of August 17, indicating a strategic decision by the shareholder [1]

Core Viewpoint - Medike (688079.SH) announced that Fengsheng Jiamei plans to reduce its shareholding by up to 12.2021 million shares, representing no more than 3% of the total share capital, starting from September 9, 2025, within a three-month period [1] Summary by Category - **Share Reduction Details** - Fengsheng Jiamei will reduce its holdings by a maximum of 12.2021 million shares, which is up to 3% of the total share capital [1] - The reduction will occur through two methods: a maximum of 4.0674 million shares (up to 1% of total share capital) will be sold via centralized bidding, and a maximum of 8.1348 million shares (up to 2% of total share capital) will be sold through block trading [1] - The selling price will be determined based on market prices [1]